文献速递免疫规划传染病防控与疫情报告

通过模拟停用前后检出率评估停用2型口服脊髓灰质炎疫苗

Evaluating cessation of the type 2 oral polio vaccine by modeling pre- and post-cessation detection rates.
PubMed 文献 · Vaccine · 2017-09-08

研究分析2010至2016年非洲和亚洲17国急性弛缓性麻痹监测数据,用β-二项模型和Ricker函数模拟停用2型口服脊髓灰质炎疫苗后Sabin样2型检出率变化。发现2型在接种活动后循环时间最长,但约50天回落至基线;停用后模型预测外发现19例异常检出,提示需加强监测。

要点

  • 2型在接种活动后循环时间最长,但Sabin样2型检出率约50天回落至基线。
  • 停用后模型预测外发现19例异常Sabin样2型检出,分布于阿富汗、印度、尼日利亚、巴基斯坦和西非。
  • 除尼日利亚因应对近期cVDPV2检出而继续使用OPV2外,Sabin样2型检出率如预测般大幅下降。

核心结论

  • 模型为停用2型口服脊髓灰质炎疫苗后Sabin样2型检出的持续时间建立了基准,异常检出提示需在特定区域加强cVDPV2暴发监测。

研究设计与样本

  • 研究分析2010至2016年非洲和亚洲17个国家的急性弛缓性麻痹监测数据。
  • 使用β-二项模型模拟Sabin样2型检出率,采用Ricker函数模拟时间依赖性。

主要发现

  • 2型在接种活动后循环时间最长,但Sabin样2型检出率约50天回落至基线水平。
  • 停用后模型预测外发现19例异常Sabin样2型检出,分布于阿富汗、印度、尼日利亚、巴基斯坦和西非。
  • 除尼日利亚因应对近期cVDPV2检出而继续使用OPV2一段时间外,Sabin样2型检出率如预测般大幅下降。

临床怎么用

  • 作者认为异常Sabin样2型检出提示特定区域需加强cVDPV2暴发监测。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The globally synchronized removal of the attenuated Sabin type 2 strain from the oral polio vaccine (OPV) in April 2016 marked a major change in polio vaccination policy. This change will provide a significant reduction in the burden of vaccine-associated paralytic polio (VAPP), but may increase the risk of circulating vaccine-derived poliovirus (cVDPV2) outbreaks during the transition period. This risk can be monitored by tracking the disappearance of Sabin-like type 2 (SL2) using data from the polio surveillance system. We studied SL2 prevalence in 17 countries in Africa and Asia, from 2010 to 2016 using acute flaccid paralysis surveillance data. We modeled the peak and decay of SL2 prevalence following mass vaccination events using a beta-binomial model for the detection rate, and a Ricker function for the temporal dependence. We found type 2 circulated the longest of all serotypes after a vaccination campaign, but that SL2 prevalence returned to baseline levels in approximately 50days. Post-cessation model predictions identified 19 anomalous SL2 detections outside of model predictions in Afghanistan, India, Nigeria, Pakistan, and western Africa. Our models established benchmarks for the duration of SL2 detection after OPV2 cessation. As predicted, SL2 detection rates have plummeted, except in Nigeria where OPV2 use continued for some time in response to recent cVDPV2 detections. However, the anomalous SL2 detections suggest specific areas that merit enhanced monitoring for signs of cVDPV2 outbreaks.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kroiss SJ, Famulare M, Lyons H, et al. Evaluating cessation of the type 2 oral polio vaccine by modeling pre- and post-cessation detection rates. Vaccine. 2017. PMID: 28890193. doi:10.1016/j.vaccine.2017.08.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。